Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 10;85(22):2114-2117.
doi: 10.1016/j.jacc.2025.04.011.

The 2025 Guideline for the Management of Patients With Acute Coronary Syndromes: Asian Perspective

Mitsuaki Sawano  1 , Xin Du  2 , Nathan D Wong  3 , Seng Chan You  4 , Duk-Woo Park  5 , Takashi Kubo  6 , Toru Kondo  7 , Ashok Seth  8 , Khurram Nasir  9 , Dennis T Ko  10 , Yuan Lu  11 , Jian'an Wang  12
Affiliations

The 2025 Guideline for the Management of Patients With Acute Coronary Syndromes: Asian Perspective

Mitsuaki Sawano et al. J Am Coll Cardiol. .
No abstract available

Keywords: ACS; Asia; coronary; guideline.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Sawano has been partially supported by research funding from Polybio, Pfizer, and Novartis through Yale University; and has received lecture honoraria from Boehringer Ingelheim. Dr Wong has received research support through UC Irvine from Amgen, Novartis, Regeneron, and Novo Nordisk; has received consultant fees from Novartis, Amgen, Heart Lung, and Ionis; and has received speaking fees from Novartis. Dr You has received grants from Daiichi-Sankyo; is a coinventor of granted Korea Patent DP-2023-1223 and DP-2023-0920, and pending Patent Applications DP-2024-0909, DP-2024-0908, DP-2022-1658, DP-2022-1478, and DP-2022-1365, all unrelated to the current work; and is chief executive officer of PHI Digital Healthcare. Dr Kubo has received consulting fees/honoraria from Abbott Medical Japan, Amgen, AstraZeneca, Boston Scientific, Daiichi-Sankyo, Nipro, Novartis Pharma, and Terumo; and has received grant/research support from Abbott Medical Japan. Dr Kondo has received lecture fees from Abbott Japan LLC, AstraZeneca KK, Boehringer Ingelheim, Ono Pharmaceutical Co, Ltd, Kowa Company, Ltd, Kyowa Kirin Co, Ltd, and Novartis Pharma KK. Dr Seth has served on the consultant and speaker bureaus for Boston Scientific, Abbott, Medtronic, Meril Lifesciences, and Shockwave Medical. Dr Lu has received support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (under awards R01HL69954 and R01HL169171), the Patient-Centered Outcomes Research Institute (under award HM-2022C2-28354), Sentara Research Foundation, and Novartis through Yale University. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

LinkOut - more resources